Company Summary
Search
Home Page
 
Supreme Pharmaceuticals Inc. 
Listed Company 
Current   Past  
Fiscal Year EndCompany StatusExempt Flag
June 30TradingN
Board of Directors
NamePosition
Allan Levien  Chairperson of the Board
  Director of the Board
David Stadnyk  Director of the Board
  President & CEO
George Tsafalas  Director of the Board
Judi Dalling  Secretary of the Board
Incorporation Locations
Inc. DateExpiry DateCountryRegionDescription
18/Jan/1982  Canada   
Exchange Filing Office
Location
Toronto Regional Service Office
Business Type(s)
Primary/SecondaryBusiness TypeDetails
Primary  Industrial  (not available) 
Securities
SymbolSecurity NameMarketStatus
FIRESupreme Pharmaceuticals Inc.TSX VentureTRADING
Name HistoryFromTo
Supreme Pharmaceuticals Inc.6/Mar/2017Present
Company Facts Reconciliation
SubjectDate Returned
Summer 2013 CFR20/Nov/2013
Associations
Auditing Firm:  MNP LLP
Lawyer:  Joanne McClusky
Transfer Agent:  Computershare Investor Services Inc.
Latest Information
TypeDateTitle
News Releases  28/Jun/2017  NEWS RELEASE - HALT[MARKET NEWS]
    NEWS RELEASE - SUPREME RECEIVES SALES APPROVAL[MARKETWIRE]
    NEWS RELEASE - IIROC TRADE RESUMPTION SUPREME PHARMACEUTICALS I[MARKET NEWS]
Bulletins  29/Jun/2017  Resume Trading
Meetings and Public Filings  Information on financial statements, public filings and corporate meetings for all Canadian public companies can be found at www.sedar.com
Property Locations
Location Name: Lillooet District Area Name:  
Effective Date: 6/Mar/2017 Location Ownership Percent: 100 
Expiry Date:  Phone: (not available)
Address: Canada
North America
Fax: (not available)
Description:  

* Historical Data